Priority 14 from the Hyperemesis Gravidarum PSP

UNCERTAINTY: Do clinical treatment guidelines for hyperemesis gravidarum improve management and outcomes? And if so how can guidelines be developed and implemented nationally (where none exist) and internationally for hospital and community settings? What should be included in guidelines? (JLA PSP Priority 14)
Overall ranking 14
JLA question ID 0090/14
Explanatory note Not available for this PSP
Evidence

Some audits of local guidelines highlight inconsistent treatment. Effectiveness of national RCOG and ACOG gudielines have not been evaluated.
Health Research Classification System category Reproductive health and childbirth
Extra information provided by this PSP
Original uncertainty examples Would there be a benefit to developing a national best practice guidance for managing HG? ~ can there be one HG protocol for every healthcare provider?  ~ Make a list of available medication along with safe dosage available to all medical professionals, as all too often treatment/medication given varies between hospitals, due to lack of information. ~ Is it possible to create a worldwide guide so docters treat everybody the same. There is so much difference between country's but even between hospitals and docters.
Submitted by Patients x 28 ~ Healthcare professionals x 6 ~ Offspring x 1 ~ Unknown x 3
PSP information
PSP unique ID 0090
PSP name Hyperemesis Gravidarum
Total number of uncertainties identified by this PSP. 65  (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop 9 October 2019